# FDA Inspection 1268427 - Transcoject GmbH - April 02, 2025

Source: https://www.keypedia.com/records/fda_inspections/transcoject-gmbh/67d6f7bb-09a2-44cf-b8d1-59722d70b893
Source feed: FDA_Inspections

> FDA Inspection 1268427 for Transcoject GmbH on April 02, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268427
- Company Name: Transcoject GmbH
- Inspection Date: 2025-04-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1268375 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/transcoject-gmbh/24e7649d-3b72-4990-b319-1ef0fbda9be2)
- [FDA Inspection 1268427 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/transcoject-gmbh/a96ecd86-150f-45a2-912a-497ff7c89de3)
- [FDA Inspection 1004177 - 2017-03-09](https://www.keypedia.com/records/fda_inspections/transcoject-gmbh/73c6c8d1-fd3d-4d41-b985-d30e1b51fff4)
- [FDA Inspection 917902 - 2015-02-19](https://www.keypedia.com/records/fda_inspections/transcoject-gmbh/9894c400-a62c-413f-9da4-9c6a037c1672)

Company: https://www.keypedia.com/companies/transcoject-gmbh/910de755-7091-4d47-b24b-65c3d9f3fd2d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d